23 Provider bias, lack of culturally competent care, and limited access to specialists contribute to these disparities
21, the FDA updated its drug shortage list and labeled the shortage of all doses of injectable semaglutide (Ozempic/Wegovy) as being resolved
Patients must confirm that they meet the BMI criteria for obesity and have no relevant contraindications.It is recommended that you consult your family doctor or an endocrinologist to learn about purchasing options and determine whether the medication is suitable for you
[8] Interestingly, vitamin B12 deficiency has similar symptoms to diabetic neuropathy, which affects an estimated 40 to 50 percent of those with type 2 diabetes at some point
The dual GIP/GLP-1 mechanism can produce different side effects than semaglutide alone, and a brief adaptation period is often wise
A comparative analysis of clinical efficacy versus social popularity